These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6311322)

  • 21. Recurrent herpes simplex infection at a smallpox vaccination site.
    Mintz L
    JAMA; 1982 May; 247(19):2704-5. PubMed ID: 7200532
    [No Abstract]   [Full Text] [Related]  

  • 22. Gender-specific predictors of genital herpes vaccine acceptance in a college population.
    Auslander BA; Rosenthal SL; Succop PA; Mills LM; Stanberry LR; Bernstein DI
    Int J STD AIDS; 2005 Jan; 16(1):27-30. PubMed ID: 15705269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Herpes vaccine.
    Mindel A
    Br J Vener Dis; 1984 Jun; 60(3):204-5. PubMed ID: 6329408
    [No Abstract]   [Full Text] [Related]  

  • 24. [Nonspecific immune stimulation with BCG in Herpes simplex recidivans. Follow-up 5 to 10 years after BCG vaccination].
    Hippmann G; Wekkeli M; Rosenkranz AR; Jarisch R; Götz M
    Wien Klin Wochenschr; 1992; 104(7):200-4. PubMed ID: 1523844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospects for control of herpes simplex virus disease through immunization.
    Stanberry LR; Cunningham AL; Mindel A; Scott LL; Spruance SL; Aoki FY; Lacey CJ
    Clin Infect Dis; 2000 Mar; 30(3):549-66. PubMed ID: 10722443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10-17 years of age: results from a randomised, controlled, double-blind trial.
    ; Abu-Elyazeed RR; Heineman T; Dubin G; Fourneau M; Leroux-Roels I; Leroux-Roels G; Richardus JH; Ostergaard L; Diez-Domingo J; Poder A; Van Damme P; Romanowski B; Blatter M; Silfverdal SA; Berglund J; Josefsson A; Cunningham AL; Flodmark CE; Tragiannidis A; Dobson S; Olafsson J; Puig-Barbera J; Mendez M; Barton S; Bernstein D; Mares J; Ratner P
    Vaccine; 2013 Dec; 31(51):6136-43. PubMed ID: 23850416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination strategies to prevent genital herpes and neonatal herpes simplex virus (HSV) disease.
    Jones CA; Cunningham AL
    Herpes; 2004 Apr; 11(1):12-7. PubMed ID: 15115632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inactivated herpes simplex virus types 1 and 2 divaccine as an agent for effective immunoprophylaxis of recurrent genital herpes].
    Barinskiĭ IF; Makhmudov FR
    Vopr Virusol; 2010; 55(1):35-40. PubMed ID: 20364670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycoprotein-D-adjuvant vaccine to prevent genital herpes.
    Stanberry LR; Spruance SL; Cunningham AL; Bernstein DI; Mindel A; Sacks S; Tyring S; Aoki FY; Slaoui M; Denis M; Vandepapeliere P; Dubin G;
    N Engl J Med; 2002 Nov; 347(21):1652-61. PubMed ID: 12444179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening to detect asymptomatic shedding of herpes simplex virus (HSV) in women with recurrent genital HSV infection.
    Barton SE; Wright LK; Link CM; Munday PE
    Genitourin Med; 1986 Jun; 62(3):181-5. PubMed ID: 3015773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seventeen years of application of herpes vaccines in Bulgaria.
    Dundarov S; Andonov P
    Acta Virol; 1994 Aug; 38(4):205-8. PubMed ID: 7879710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of herpes simplex virus types 1 and 2 isolated in patients with herpes genitalis in Sheffield.
    Barton IG; Kinghorn GR; Najem S; Al-Omar LS; Potter CW
    Br J Vener Dis; 1982 Feb; 58(1):44-7. PubMed ID: 6275940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The potential epidemiological impact of a genital herpes vaccine for women.
    Garnett GP; Dubin G; Slaoui M; Darcis T
    Sex Transm Infect; 2004 Feb; 80(1):24-9. PubMed ID: 14755031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjects.
    de Bruyn G; Vargas-Cortez M; Warren T; Tyring SK; Fife KH; Lalezari J; Brady RC; Shahmanesh M; Kinghorn G; Beutner KR; Patel R; Drehobl MA; Horner P; Kurtz TO; McDermott S; Wald A; Corey L
    Vaccine; 2006 Feb; 24(7):914-20. PubMed ID: 16213066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs.
    Bourne N; Bravo FJ; Francotte M; Bernstein DI; Myers MG; Slaoui M; Stanberry LR
    J Infect Dis; 2003 Feb; 187(4):542-9. PubMed ID: 12599070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Follow-up of pregnant women with high risk of herpes infections].
    Suárez M; Saavedra T; Schultz R; Briones H
    Rev Chil Obstet Ginecol; 1987; 52(5):292-5. PubMed ID: 2856306
    [No Abstract]   [Full Text] [Related]  

  • 37. Virological screening for herpes simplex virus during pregnancy.
    Lancet; 1988 Sep; 2(8613):722-3. PubMed ID: 2901573
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunization against genital herpes with a vaccine virus that has defects in productive and latent infection.
    Da Costa XJ; Jones CA; Knipe DM
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6994-8. PubMed ID: 10359827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does frequency of genital herpes recurrences predict risk of transmission? Further analysis of the valacyclovir transmission study.
    Kim HN; Wald A; Harris J; Almekinder J; Heitman C; Corey L
    Sex Transm Dis; 2008 Feb; 35(2):124-8. PubMed ID: 17921912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection.
    Hollier LM; Wendel GD
    Cochrane Database Syst Rev; 2008 Jan; (1):CD004946. PubMed ID: 18254066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.